Great news!
Stanford University has finished its second study on treating fibromyalgia with low-dose naltrexone, with very good results and no side effects reported.
My son and I both take low-dose naltrexone (LDN) - I have taken it for over 5 years - and it has helped us both. Here is a blog post on my own experience with LDN.
Here are two excellent websites for more information on LDN. Both include details on exactly how LDN works, and links to research studies on its use (of course, there have been no studies yet on LDN and ME/CFS!):
LDNers
LDN Science (check out the video on the homepage that shows how LDN works)
Also, a pharmaceutical company has purchased the patent for LDN (at 4.5 mg) and has applied for FDA approval. Since this is a different dose of a drug already on the market for decades (naltrexone at 50 mg), approval should come quickly. Then, LDN will be available through any drugstore rather than having to go through a compounding pharmacy. This will make the treatment far more appealing to mainstream doctors, and the company has pledged to keep the cost reasonable (at less than a dollar a day).
This is all great news for CFS and FM patients!
I have had Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) since March 2002. Both of my sons also got ME/CFS at ages 6 and 10. Our younger son fully recovered after 10 years of mild illness. Our older son still has ME/CFS and also has Lyme disease plus two other tick infections. This blog is about how our family lives with chronic illness, with a focus on improving our conditions and enjoying our lives in spite of these challenges.
No comments:
Post a Comment